147 related articles for article (PubMed ID: 37682330)
1. Quantitative diffusion-weighted MRI response assessment in rhabdomyosarcoma: an international retrospective study on behalf of the European paediatric Soft tissue sarcoma Study Group Imaging Committee.
van Ewijk R; Chatziantoniou C; Adams M; Bertolini P; Bisogno G; Bouhamama A; Caro-Dominguez P; Charon V; Coma A; Dandis R; Devalck C; De Donno G; Ferrari A; Fiocco M; Gallego S; Giraudo C; Glosli H; Ter Horst SAJ; Jenney M; Klein WM; Leemans A; Leseur J; Mandeville HC; McHugh K; Merks JHM; Minard-Colin V; Moalla S; Morosi C; Orbach D; Ording Muller LS; Pace E; Di Paolo PL; Perruccio K; Quaglietta L; Renard M; van Rijn RR; Ruggiero A; Sirvent SI; De Luca A; Schoot RA
Pediatr Radiol; 2023 Nov; 53(12):2539-2551. PubMed ID: 37682330
[TBL] [Abstract][Full Text] [Related]
2. Adolescents and young adults with rhabdomyosarcoma treated in the European paediatric Soft tissue sarcoma Study Group (EpSSG) protocols: a cohort study.
Ferrari A; Chisholm JC; Jenney M; Minard-Colin V; Orbach D; Casanova M; Guillen G; Glosli H; van Rijn RR; Schoot RA; Cameron AL; Rogers T; Alaggio R; Ben-Arush M; Mandeville HC; Devalck C; Defachelles AS; Coppadoro B; Bisogno G; Merks JHM
Lancet Child Adolesc Health; 2022 Aug; 6(8):545-554. PubMed ID: 35690071
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of soft-tissue lymphoma from undifferentiated sarcoma: apparent diffusion coefficient histogram analysis.
Hong JH; Jee WH; Whang S; Jung CK; Chung YG; Cho SG
Acta Radiol; 2021 Aug; 62(8):1045-1051. PubMed ID: 32847366
[TBL] [Abstract][Full Text] [Related]
4. Orbital infantile hemangioma and rhabdomyosarcoma in children: differentiation using diffusion-weighted magnetic resonance imaging.
Kralik SF; Haider KM; Lobo RR; Supakul N; Calloni SF; Soares BP
J AAPOS; 2018 Feb; 22(1):27-31. PubMed ID: 29113884
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric MRI with diffusion-weighted imaging in predicting response to chemotherapy in cases of osteosarcoma and Ewing's sarcoma.
Saleh MM; Abdelrahman TM; Madney Y; Mohamed G; Shokry AM; Moustafa AF
Br J Radiol; 2020 Nov; 93(1115):20200257. PubMed ID: 32706980
[TBL] [Abstract][Full Text] [Related]
6. Use of Diffusion-Weighted Magnetic Resonance Imaging and Apparent Diffusion Coefficient in Gastric Cancer Staging.
Soydan L; Demir AA; Torun M; Cikrikcioglu MA
Curr Med Imaging; 2020; 16(10):1278-1289. PubMed ID: 32108000
[TBL] [Abstract][Full Text] [Related]
7. Chemical-shift and diffusion-weighted magnetic resonance imaging of thymus in myasthenia gravis: usefulness of quantitative assessment.
Priola AM; Priola SM; Giraudo MT; Gned D; Giardino R; Marci V; Errico L; Veltri A
Invest Radiol; 2015 Apr; 50(4):228-38. PubMed ID: 25478741
[TBL] [Abstract][Full Text] [Related]
8. Does the apparent diffusion coefficient from diffusion-weighted MRI imaging aid in the characterization of malignant soft tissue tumors and sarcomas.
Gowda P; Bajaj G; Silva FD; Ashikyan O; Xi Y; Chhabra A
Skeletal Radiol; 2023 Aug; 52(8):1475-1484. PubMed ID: 36725723
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy response evaluation using diffusion weighted MRI in Ewing Sarcoma: A single center experience.
Kayal EB; Alampally JT; Sharma R; Bakhshi S; Mehndiratta A; Kumar R; Chandrashekhara SH; Jana M; Bhalla AS; Sharma MC; Mridha AR; Vishnubhatla S; Kandasamy D
Acta Radiol; 2023 Apr; 64(4):1508-1517. PubMed ID: 36071615
[TBL] [Abstract][Full Text] [Related]
10. European guideline for imaging in paediatric and adolescent rhabdomyosarcoma - joint statement by the European Paediatric Soft Tissue Sarcoma Study Group, the Cooperative Weichteilsarkom Studiengruppe and the Oncology Task Force of the European Society of Paediatric Radiology.
van Ewijk R; Schoot RA; Sparber-Sauer M; Ter Horst SAJ; Jehanno N; Borgwardt L; de Keizer B; Merks JHM; de Luca A; McHugh K; von Kalle T; Schäfer JF; van Rijn RR;
Pediatr Radiol; 2021 Sep; 51(10):1940-1951. PubMed ID: 34137936
[TBL] [Abstract][Full Text] [Related]
11. The value of diffusion weighted imaging and apparent diffusion coefficient in primary Osteogenic and Ewing sarcomas for the monitoring of response to treatment: Initial experience.
Asmar K; Saade C; Salman R; Saab R; Khoury NJ; Abboud M; Tamim H; Makki M; Naffaa L
Eur J Radiol; 2020 Mar; 124():108855. PubMed ID: 32018075
[TBL] [Abstract][Full Text] [Related]
12. Therapy Response Assessment of Pediatric Tumors with Whole-Body Diffusion-weighted MRI and FDG PET/MRI.
Theruvath AJ; Siedek F; Muehe AM; Garcia-Diaz J; Kirchner J; Martin O; Link MP; Spunt S; Pribnow A; Rosenberg J; Herrmann K; Gatidis S; Schäfer JF; Moseley M; Umutlu L; Daldrup-Link HE
Radiology; 2020 Jul; 296(1):143-151. PubMed ID: 32368961
[TBL] [Abstract][Full Text] [Related]
13. Near-Silent and Distortion-Free Diffusion MRI in Pediatric Musculoskeletal Disorders: Comparison With Echo Planar Imaging Diffusion.
Sandberg JK; Young VA; Syed AB; Yuan J; Hu Y; Sandino C; Menini A; Hargreaves B; Vasanawala S
J Magn Reson Imaging; 2021 Feb; 53(2):504-513. PubMed ID: 32815203
[TBL] [Abstract][Full Text] [Related]
14. Non-parameningeal head and neck rhabdomyosarcoma in children, adolescents, and young adults: Experience of the European paediatric Soft tissue sarcoma Study Group (EpSSG) - RMS2005 study.
Glosli H; Bisogno G; Kelsey A; Chisholm JC; Gaze M; Kolb F; McHugh K; Shipley J; Gallego S; Merks JHM; Smeele LE; Mandeville H; Ferrari A; Minard-Colin V; Corradini N; Jenney M; Zanetti I; De Salvo GL; Orbach D;
Eur J Cancer; 2021 Jul; 151():84-93. PubMed ID: 33971448
[TBL] [Abstract][Full Text] [Related]
15. Distortion-free diffusion MRI using an MRI-guided Tri-Cobalt 60 radiotherapy system: Sequence verification and preliminary clinical experience.
Gao Y; Han F; Zhou Z; Cao M; Kaprealian T; Kamrava M; Wang C; Neylon J; Low DA; Yang Y; Hu P
Med Phys; 2017 Oct; 44(10):5357-5366. PubMed ID: 28692129
[TBL] [Abstract][Full Text] [Related]
16. Impact of Alternate
Partridge SC; Steingrimsson J; Newitt DC; Gibbs JE; Marques HS; Bolan PJ; Boss MA; Chenevert TL; Rosen MA; Hylton NM
Tomography; 2022 Mar; 8(2):701-717. PubMed ID: 35314635
[TBL] [Abstract][Full Text] [Related]
17. Feasibility and possible value of quantitative semi-automated diffusion weighted imaging volumetry of neuroblastic tumors.
Gassenmaier S; Tsiflikas I; Fuchs J; Grimm R; Urla C; Esser M; Maennlin S; Ebinger M; Warmann SW; Schäfer JF
Cancer Imaging; 2020 Dec; 20(1):89. PubMed ID: 33334369
[TBL] [Abstract][Full Text] [Related]
18. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
[TBL] [Abstract][Full Text] [Related]
19. Multi-site clinical evaluation of DW-MRI as a treatment response metric for breast cancer patients undergoing neoadjuvant chemotherapy.
Galbán CJ; Ma B; Malyarenko D; Pickles MD; Heist K; Henry NL; Schott AF; Neal CH; Hylton NM; Rehemtulla A; Johnson TD; Meyer CR; Chenevert TL; Turnbull LW; Ross BD
PLoS One; 2015; 10(3):e0122151. PubMed ID: 25816249
[TBL] [Abstract][Full Text] [Related]
20. Assessment and quantification of sources of variability in breast apparent diffusion coefficient (ADC) measurements at diffusion weighted imaging.
Giannotti E; Waugh S; Priba L; Davis Z; Crowe E; Vinnicombe S
Eur J Radiol; 2015 Sep; 84(9):1729-36. PubMed ID: 26078100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
